netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Results

Looking for Rituximab found 14 matches

Formulary BNF Category
  Cytotoxic Drug  Rituximab  (MabThera) Anti-lymphocyte monoclonal antibodies - 08.02.03
  Rituximab Biologics - 10.01.03
  Rituximab IV Infusion Cytotoxics and Monoclonal Antibodies - 24.03
  Rituximab SC Injection Cytotoxics and Monoclonal Antibodies - 24.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update December 2009: Rituximab: progressive multifocal leukoencephalopathy in a patient without prior treatment for RA (10.01.03)
link in drug section MHRA Drug Safety Update, December 2013: Rituximab: screen for hepatitis B virus before treatment (10.01.03)
link in drug section MHRA Drug Safety Update, December 2013: Rituximab: Screen for hepatitis b virus before treatment (08.02.03)
link in drug section NICE TA137: Lymphoma (follicular non-Hodgkins) - rituximab (08.02.03)
link in drug section NICE TA174: Leukaemia (chronic lymphocytic, first line) - rituximab (08.02.03)
link in drug section NICE TA193: Leukaemia (chronic lymphocytic, relapsed) - rituximab  (08.02.03)
link in drug section NICE TA226: Rituximab for the first-line maintenance treatment of follicular non-Hodgkin’s lymphoma (08.02.03)
link in drug section NICE TA243:Rituximab for the first-line treatment of stage III-IV follicular lymphoma (January 2012) (08.02.03)
link in drug section NICE TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (08.02.03)
link in drug section NICE TA65: Rituximab for aggressive non-Hodgkin’s lymphoma (08.02.03)


 

netFormulary